In the news
Karmanos Cancer Center first in Midwest to offer latest Molecular Breast Imaging
December 4, 2012
The Barbara Ann Karmanos Cancer Center is the first hospital in the Midwest to offer the newest molecular breast imaging device - GE Healthcare's Discovery* NM750b. This molecular breast imaging (MBI) technology makes it possible to detect breast cancer in women considered to be at high-risk, especially those with dense breast tissue. "Although molecular breast imaging does not take the place of mammography, it offers another option for patients who need additional imaging, such as magnetic resonance imaging (MRI)," said Dr. Sharon Helmer, clinical service chief, Imaging Department, and director, Breast Imaging, Karmanos Cancer Center; and clinical associate professor, Wayne State University School of Medicine. "The MBI system allows better detection of very small lesions in women with dense breast tissue. Not only will this help eliminate false positives, it may help to detect breast cancers earlier when the disease is highly survivable."